The UK’s transplant system, once regarded as a global leader, is now struggling to keep pace with other Western countries. Despite steady levels of organ donation, the number of heart and lung transplants carried out each year has remained largely unchanged for decades. Hundreds of patients remain on waiting lists, often facing long delays for life-saving procedures.

Investigations have highlighted several challenges, including outdated equipment, limited funding and a shortage of specialist staff. In some cases, suitable donor organs are not used due to insufficient diagnostic technology or capacity within hospitals. A lack of theatre space, intensive care beds and available staff has also meant that operations cannot always go ahead, even when organs are available.

Concerns have also been raised about the quality of follow-up care after transplantation. Long-term support is essential to manage complications and ensure successful outcomes, yet survival rates in the UK lag behind those seen in leading countries. Patients have reported difficulties accessing consistent care, particularly when dealing with the side effects of ongoing treatment.

There are also significant regional differences in waiting times and access to services across transplant centres. Experts warn that without greater investment and improved coordination, the system risks further decline. While officials acknowledge the issues and have pledged reforms, many within the field believe urgent action is needed to restore the UK’s standing and improve outcomes for patients.

Health officials have confirmed that the worst phase of a meningitis outbreak in Kent, believed to be linked to a nightclub in Canterbury, has now passed. In total, 29 confirmed or suspected cases have been associated with the incident, which has resulted in two fatalities. While authorities report a decline in numbers following further testing, they caution that additional cases may still emerge.

Revised figures show a slight reduction in both confirmed and suspected infections, with no further changes reported since the latest update. Officials stress that ongoing monitoring remains essential to fully understand how the outbreak developed and to ensure it is properly contained.

The situation has had a significant impact on the local student population, particularly as it coincided with an already demanding academic period. Many individuals have experienced heightened symptomsand disruption, though there are signs that concern is beginning to ease as preventative measures take effect.

In response, vaccination and antibiotic clinics have been re-established across several locations in Kent. Thousands of people have already received treatment as part of efforts to limit further spread. The outbreak has been linked to the MenB strain, which was only introduced into routine vaccination programmes in 2015, leaving many young adults without prior protection.

A new survey across Guernsey schools is aiming to better understand how smartphone use is affecting the health and wellbeing of pupils under 16. Commissioned by the States, the study will gather insights from students, parents and school staff to build a clearer picture of how devices are used during the school day.

The research, led by the University of the West of England, will examine both the benefits and potential harms linked to smartphone use. Alongside learning and communication, the survey will explore how screen time may influence mental health, including anxiety, online interactions and exposure to harmful content. All responses will remain anonymous, with findings expected later this year.

Health officials say the study reflects growing concerns around the wider impact of digital habits on young people. It will consider issues such as social pressures, online contact from strangers and friendship breakdowns, all of which can affect emotional wellbeing. The aim is to better understand how these factors may shape children’s experiences both in and outside the classroom.

Authorities have stressed the survey is not a reaction to specific problems in local schools, but rather a proactive step to gather evidence. The findings could help inform future policies, including discussions around limiting phone use in schools, while supporting a more balanced approach to young people’s health and development.

A patient watchdog has warned that a divide in healthcare access is developing, as more people turn to private providers to avoid long NHS waiting times. Healthwatch England reports that both patient feedback and survey data indicate a clear increase in private healthcare use, with delays in NHS treatment being a major driving factor.

A survey of nearly 2,600 adults found that 16% had paid for private care in the past year, compared with 9% two years ago. Of those, around 40% said lengthy NHS waits influenced their decision. The findings also highlight inequality, with 35% of people earning over £80,000 opting for private care, compared with just 10% of those earning under £20,000.

Some patients are using private services strategically, paying for quicker scans or tests before returning to the NHS for treatment. Private providers say this approach is becoming more common, particularly as NHS diagnostic targets stretch to six weeks, while private appointments can be arranged within days. Demand for private GP visits, mental health support and weight-loss treatments is also increasing.

Healthwatch England is urging the government to improve waiting times and provide clearer communication for patients awaiting care. Medical professionals warn that this trend is placing additional strain on NHS services. The government says investment and reforms are helping reduce backlogs, but acknowledges that significant challenges remain.

Hospitals across England are being urged to speed up treatment for patients waiting for planned care as the government places renewed focus on reducing NHS backlogs. Improving waiting times has become one of the central health priorities for the current parliament, with ministers aiming to bring down the number of people facing long delays for non-emergency procedures.

Under the latest target, at least 65% of patients should be treated within 18 weeks of being referred by the end of March 2026. The 18-week standard is a long-standing benchmark used to measure how quickly patients receive planned operations, specialist consultations and other routine hospital care.

To help reach that goal, each NHS trust has been set its own improvement target. Hospitals are expected to either ensure that 60% of patients are treated within 18 weeks or increase their performance by at least five percentage points compared with their figures from November 2024 — whichever represents the greater improvement.

Health officials say this is only an interim step in a wider recovery plan for the NHS. The long-term ambition is to restore waiting times closer to previous standards, with a target that 92% of patients should receive treatment within 18 weeks by July 2029. Achieving this would represent a major reduction in the treatment backlog that has grown significantly in recent years.

Many family doctors say they have never refused a patient’s request to be signed off work due to mental health concerns. In a survey of more than 5,000 GPs across England, 752 responded, with 540 saying they had never rejected such a request. A further 162 said they had turned down at least one request, while 50 preferred not to comment. Several doctors argued that deciding whether someone should be declared unfit for work should not be a core responsibility of general practitioners.

Some GPs described the role as challenging because it places them in the difficult position of both supporting patients and judging whether time off work is appropriate. Doctors warned this can damage the doctor–patient relationship, as people often visit their GP seeking support rather than assessment. A number of practitioners also reported tensions when requests are refused, with some patients becoming confrontational or refusing to leave until a fit note is issued.

The number of fit notes issued has risen steadily in recent years. Data shows that mental health and behavioural conditions are now the most common reason cited, accounting for more than 956,000 notes last year. However, in many cases the notes do not specify a particular cause. While fit notes can suggest adjustments that might allow someone to remain in work, most still sign individuals off completely.

There are growing calls to review how the system operates. Some experts believe GPs may not always have the time or occupational health expertise needed to assess a person’s ability to work long term. As a result, new approaches are being explored, including workplace support schemes and return-to-work plans developed jointly by employers and health professionals.

NHS England has temporarily halted new prescriptions of cross-sex hormones for 16 and 17-year-olds experiencing gender dysphoria while it reviews the evidence surrounding the treatment. The decision follows concerns raised in recent research suggesting that existing studies on the benefits and risks of the medication for young people are limited and inconclusive.

Cross-sex hormones, such as testosterone and oestrogen, are used to help individuals develop physical traits that align more closely with their gender identity rather than their biological sex. These treatments can cause long-term or irreversible physical changes, including voice deepening or breast development. Under the updated position, teenagers who are already receiving the medication will continue their treatment, although clinicians have been asked to reassess their care plans.

The pause comes after an extensive review commissioned by NHS England examined available research on the impact of these hormones on young people’s wellbeing, including mental health and quality of life. The findings suggested that the current evidence base is not strong enough to determine whether the treatment is clearly beneficial or potentially harmful for patients under the age of 18. As a result, the health service will consult with medical professionals, advocacy organisations and the public before deciding on long-term guidance.

Reactions to the move have been mixed. Some advocacy groups have criticised the decision and suggested legal action may be considered, while others have welcomed a cautious approach, arguing that further research is necessary before prescribing treatments with potentially permanent effects to young people.

Schools across England will soon be required to introduce mandatory allergy awareness training for all staff under new statutory guidance announced by the Department for Education. The updated measures also require schools to keep spare adrenaline auto-injectors on site so that children experiencing severe allergic reactions can be treated quickly, even if they have not previously been diagnosed with an allergy.

The new guidance forms part of wider efforts to improve safety for children with allergies and to create consistent standards across the education system. Allergy-related illnesses and medical appointments are believed to cause significant disruption to learning each year, with hundreds of thousands of school days lost. Officials hope the new approach will both protect pupils and help reduce unnecessary absences from school.

Under the proposed rules, schools will need to ensure staff understand how to recognise the signs of allergic reactions, including anaphylaxis, and how to respond appropriately in an emergency. The Department for Education says many schools already follow similar practices but making them compulsory will ensure every school meets the same safety expectations.

While the plans have been broadly welcomed, school leaders have warned that implementing the requirements will involve additional costs for training, equipment and staff time. Education leaders say the measures are important for pupil safety but have emphasised that adequate funding will be needed to support schools in putting the guidance into practice before it comes into effect in September.